Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.

Use of DOACs in patients with ICH and AF resulted in a remarkable reduction in ischemic stroke, but that benefit was partially offset by an increase in ICH recurrence.

Systemic medications, particularly selective beta blockers and calcium channel blockers, can significantly influence intraocular pressure (IOP) over time, according to study results published in ...

High blood pressure is a major risk factor for heart disease. Here are some common questions you may have about blood ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

Blockages in coronary arteries cause sudden heart attacks, leading to heart muscle damage. In contrast, heart failure is a ...

A recent study from the University of Bologna has found that women taking beta-blockers for high blood pressure may have a ...

All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted ...

When Bre first began experiencing overwhelming fatigue as a child, her doctors assumed the culprit was asthma. However, it ...

Switching from beta-blockers to digoxin as first line therapy for older patients with AF could produce £100m in NHS savings annually.